Recent studies have demonstrated an important role of HIF-1 in resistance to chemotherapeutic agents such as platinum-containing anti-cancer drugs, e.g. through regulation of XPA (xeroderma pigmentosum group A) protein that senses DNA damage and recruits other DNA repair proteins to the damaged template in the nucleotide excision repair pathway [21, 22]. Here, HIF1A is linked to cancer.